Collection: Growth Hormone & GH-Releasing Research Peptides UK

Our growth hormone and GH-releasing research peptides collection features compounds studied for their roles in the hypothalamic-pituitary-somatotropic axis, including GH secretagogue receptor (GHS-R) agonism and GHRH-receptor activation. Available to UK researchers for in vitro and preclinical laboratory investigation, this range includes Ipamorelin, CJC-1295 No DAC + Ipamorelin, and Tesamorelin — all produced to ≥99% purity with independent HPLC verification.

These compounds are investigated in models of GH secretion kinetics, IGF-1 axis modulation, lipodystrophy, body composition, and pulsatile versus continuous GH release. Tesamorelin is a synthetic GHRH analogue with an established clinical trial history; Ipamorelin is a highly selective GHS-R agonist; CJC-1295 No DAC provides shorter-acting GHRH-receptor stimulation in research models. Available in vial and cartridge formats with CoA documentation.

All products are supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary use.